Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report.

Ichim TE, Solano F, Lara F, Paris E, Ugalde F, Rodriguez JP, Minev B, Bogin V, Ramos F, Woods EJ, Murphy MP, Patel AN, Harman RJ, Riordan NH.

Int Arch Med. 2010 Nov 11;3:30. doi: 10.1186/1755-7682-3-30.

2.

Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.

Syková E, Jendelová P, Urdzíková L, Lesný P, Hejcl A.

Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1113-29. Epub 2006 Apr 22. Review.

PMID:
16633897
3.

Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.

Liu J, Han D, Wang Z, Xue M, Zhu L, Yan H, Zheng X, Guo Z, Wang H.

Cytotherapy. 2013 Feb;15(2):185-91. doi: 10.1016/j.jcyt.2012.09.005.

PMID:
23321330
4.

Bone marrow mesenchymal stromal cells and olfactory ensheathing cells transplantation after spinal cord injury--a morphological and functional comparison in rats.

Torres-Espín A, Redondo-Castro E, Hernández J, Navarro X.

Eur J Neurosci. 2014 May;39(10):1704-17. doi: 10.1111/ejn.12542. Epub 2014 Mar 18.

PMID:
24635194
5.

Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury.

Derakhshanrad N, Saberi H, Tayebi Meybodi K, Taghvaei M, Arjmand B, Aghayan HR, Kohan AH, Haghpanahi M, Rahmani S.

Basic Clin Neurosci. 2015 Oct;6(4):299-305.

6.

Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats.

Roh DH, Seo MS, Choi HS, Park SB, Han HJ, Beitz AJ, Kang KS, Lee JH.

Cell Transplant. 2013;22(9):1577-90. doi: 10.3727/096368912X659907. Epub 2013 Jan 2.

PMID:
23294734
7.

Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report.

Dlouhy BJ, Awe O, Rao RC, Kirby PA, Hitchon PW.

J Neurosurg Spine. 2014 Oct;21(4):618-22. doi: 10.3171/2014.5.SPINE13992. Epub 2014 Jul 8.

PMID:
25002238
8.

Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.

Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, Dixit A, Rauthan A, Murgod U, Totey S.

Cytotherapy. 2009;11(7):897-911. doi: 10.3109/14653240903253857.

PMID:
19903102
9.

Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.

Li ZY, Wang CQ, Lu G, Pan XY, Xu KL.

Cell Biochem Biophys. 2014 Sep;70(1):115-22. doi: 10.1007/s12013-014-9866-y.

PMID:
24696072
10.

Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury.

Jarocha D, Milczarek O, Wedrychowicz A, Kwiatkowski S, Majka M.

Cell Transplant. 2015;24(4):661-72. doi: 10.3727/096368915X687796. Epub 2015 Mar 24.

PMID:
25807231
11.

Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury.

Tabakow P, Jarmundowicz W, Czapiga B, Fortuna W, Miedzybrodzki R, Czyz M, Huber J, Szarek D, Okurowski S, Szewczyk P, Gorski A, Raisman G.

Cell Transplant. 2013;22(9):1591-612. doi: 10.3727/096368912X663532.

PMID:
24007776
12.

Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment.

Watanabe S, Uchida K, Nakajima H, Matsuo H, Sugita D, Yoshida A, Honjoh K, Johnson WE, Baba H.

Stem Cells. 2015 Jun;33(6):1902-14. doi: 10.1002/stem.2006.

13.

Co-transplantation of olfactory ensheathing glia and mesenchymal stromal cells does not have synergistic effects after spinal cord injury in the rat.

Amemori T, Jendelová P, Růzicková K, Arboleda D, Syková E.

Cytotherapy. 2010 Apr;12(2):212-25. doi: 10.3109/14653240903440103.

PMID:
20196694
14.

Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats.

Urdzíková L, Jendelová P, Glogarová K, Burian M, Hájek M, Syková E.

J Neurotrauma. 2006 Sep;23(9):1379-91.

PMID:
16958589
15.

Intranasal delivery of bone marrow stromal cells to spinal cord lesions.

Ninomiya K, Iwatsuki K, Ohnishi Y, Ohkawa T, Yoshimine T.

J Neurosurg Spine. 2015 Jul;23(1):111-9. doi: 10.3171/2014.10.SPINE14690. Epub 2015 Apr 3.

PMID:
25840039
16.

Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury.

Neirinckx V, Agirman G, Coste C, Marquet A, Dion V, Rogister B, Franzen R, Wislet S.

Stem Cell Res Ther. 2015 Nov 4;6:211. doi: 10.1186/s13287-015-0202-2.

17.

Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.

Satti HS, Waheed A, Ahmed P, Ahmed K, Akram Z, Aziz T, Satti TM, Shahbaz N, Khan MA, Malik SA.

Cytotherapy. 2016 Apr;18(4):518-22. doi: 10.1016/j.jcyt.2016.01.004.

PMID:
26971680
18.

Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.

Ahn SH, Park HW, Lee BS, Moon HW, Jang SH, Sakong J, Bae JH.

Spine (Phila Pa 1976). 2003 Feb 15;28(4):341-6; discussion 346-7.

PMID:
12590206
20.

Safety profile, feasibility and early clinical outcome of cotransplantation of olfactory mucosa and bone marrow stem cells in chronic spinal cord injury patients.

Goni VG, Chhabra R, Gupta A, Marwaha N, Dhillon MS, Pebam S, Gopinathan NR, Bangalore Kantharajanna S.

Asian Spine J. 2014 Aug;8(4):484-90. doi: 10.4184/asj.2014.8.4.484. Epub 2014 Aug 19.

Supplemental Content

Support Center